Financial Metrics

MEDP Medpace Holdings, Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.11	—	USD/shares	10-Q	2017-05-02
Quarterly	2016-06-30	0.15	+36.4%	USD/shares	10-Q	2017-08-01
Quarterly	2016-09-30	0.13	-13.3%	USD/shares	10-Q	2017-10-31
Quarterly	2017-03-31	0.2	+53.8%	USD/shares	10-Q	2018-05-01
Quarterly	2017-06-30	0.23	+15.0%	USD/shares	10-Q	2018-07-31
Quarterly	2017-09-30	0.25	+8.7%	USD/shares	10-Q	2018-10-30
Quarterly	2018-03-31	0.4	+60.0%	USD/shares	10-Q	2019-04-30
Quarterly	2018-06-30	0.45	+12.5%	USD/shares	10-Q	2019-07-30
Quarterly	2018-09-30	0.52	+15.6%	USD/shares	10-Q	2019-10-29
Quarterly	2019-03-31	0.51	-1.9%	USD/shares	10-Q	2020-04-29
Quarterly	2019-06-30	0.73	+43.1%	USD/shares	10-Q	2020-07-28
Quarterly	2019-09-30	0.63	-13.7%	USD/shares	10-Q	2020-10-27
Quarterly	2020-03-31	0.76	+20.6%	USD/shares	10-Q	2021-04-27
Quarterly	2020-06-30	0.64	-15.8%	USD/shares	10-Q	2021-07-27
Quarterly	2020-09-30	1.09	+70.3%	USD/shares	10-Q	2021-10-26
Quarterly	2021-03-31	1.14	+4.6%	USD/shares	10-Q	2022-04-26
Quarterly	2021-06-30	1.06	-7.0%	USD/shares	10-Q	2022-07-26
Quarterly	2021-09-30	1.29	+21.7%	USD/shares	10-Q	2022-10-25
Quarterly	2022-03-31	1.69	+31.0%	USD/shares	10-Q	2023-04-25
Quarterly	2022-06-30	1.46	-13.6%	USD/shares	10-Q	2023-07-25
Quarterly	2022-09-30	2.05	+40.4%	USD/shares	10-Q	2023-10-24
Quarterly	2023-03-31	2.27	+10.7%	USD/shares	10-Q	2024-04-23
Quarterly	2023-06-30	1.93	-15.0%	USD/shares	10-Q	2024-07-23
Quarterly	2023-09-30	2.22	+15.0%	USD/shares	10-Q	2024-10-22
Quarterly	2024-03-31	3.2	+44.1%	USD/shares	10-Q	2025-04-22
Quarterly	2024-06-30	2.75	-14.1%	USD/shares	10-Q	2025-07-22
Quarterly	2024-09-30	3.01	+9.5%	USD/shares	10-Q	2025-10-23
Quarterly	2025-03-31	3.67	+21.9%	USD/shares	10-Q	2025-04-22
Quarterly	2025-06-30	3.1	-15.5%	USD/shares	10-Q	2025-07-22
Quarterly	2025-09-30	3.86	+24.5%	USD/shares	10-Q	2025-10-23
Annual	2016-12-31	0.37	—	USD/shares	10-K	2019-02-26
Annual	2017-12-31	0.98	+164.9%	USD/shares	10-K	2020-02-25
Annual	2018-12-31	1.97	+101.0%	USD/shares	10-K	2021-02-16
Annual	2019-12-31	2.67	+35.5%	USD/shares	10-K	2022-02-15
Annual	2020-12-31	3.84	+43.8%	USD/shares	10-K	2023-02-14
Annual	2021-12-31	4.81	+25.3%	USD/shares	10-K	2024-02-13
Annual	2022-12-31	7.28	+51.4%	USD/shares	10-K	2025-02-11
Annual	2023-12-31	8.88	+22.0%	USD/shares	10-K	2026-02-10
Annual	2024-12-31	12.63	+42.2%	USD/shares	10-K	2026-02-10
Annual	2025-12-31	15.28	+21.0%	USD/shares	10-K	2026-02-10

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-09-30	165006000.0	—	USD	10-Q	2016-11-03
Quarterly	2016-12-31	151267000.0	-8.3%	USD	10-Q	2017-10-31
Quarterly	2017-03-31	161906000.0	+7.0%	USD	10-Q	2017-05-02
Quarterly	2017-06-30	143191000.0	-11.6%	USD	10-Q	2017-08-01
Quarterly	2017-09-30	169152000.0	+18.1%	USD	10-Q	2017-10-31
Quarterly	2017-12-31	205111000.0	+21.3%	USD	10-Q	2018-10-30
Quarterly	2018-03-31	181067000.0	-11.7%	USD	10-Q	2018-05-01
Quarterly	2018-06-30	147021000.0	-18.8%	USD	10-Q	2018-07-31
Quarterly	2018-09-30	113689000.0	-22.7%	USD	10-Q	2018-10-30
Quarterly	2018-12-31	79721000.0	-29.9%	USD	10-Q	2019-10-29
Quarterly	2019-03-31	55781000.0	-30.0%	USD	10-Q	2019-04-30
Quarterly	2019-06-30	0.0	-100.0%	USD	10-Q	2019-07-30
Quarterly	2019-09-30	0.0	—	USD	10-Q	2019-10-29
Annual	2016-12-31	151267000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	205111000.0	+35.6%	USD	10-K	2019-02-26
Annual	2018-12-31	79721000.0	-61.1%	USD	10-K	2020-02-25
Annual	2019-12-31	0.0	-100.0%	USD	10-K	2020-02-25

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	3456000.0	—	USD	10-Q	2017-05-02
Quarterly	2016-06-30	5693000.0	+64.7%	USD	10-Q	2017-08-01
Quarterly	2016-09-30	7843000.0	+37.8%	USD	10-Q	2017-10-31
Quarterly	2017-03-31	4374000.0	-44.2%	USD	10-Q	2018-05-01
Quarterly	2017-06-30	6019000.0	+37.6%	USD	10-Q	2018-07-31
Quarterly	2017-09-30	8329000.0	+38.4%	USD	10-Q	2018-10-30
Quarterly	2018-03-31	3951000.0	-52.6%	USD	10-Q	2019-04-30
Quarterly	2018-06-30	9793000.0	+147.9%	USD	10-Q	2019-07-30
Quarterly	2018-09-30	12575000.0	+28.4%	USD	10-Q	2019-10-29
Quarterly	2019-03-31	2520000.0	-80.0%	USD	10-Q	2020-04-29
Quarterly	2019-06-30	5990000.0	+137.7%	USD	10-Q	2020-07-28
Quarterly	2019-09-30	12152000.0	+102.9%	USD	10-Q	2020-10-27
Quarterly	2020-03-31	5561000.0	-54.2%	USD	10-Q	2021-04-27
Quarterly	2020-06-30	14885000.0	+167.7%	USD	10-Q	2021-07-27
Quarterly	2020-09-30	23554000.0	+58.2%	USD	10-Q	2021-10-26
Quarterly	2021-03-31	6507000.0	-72.4%	USD	10-Q	2022-04-26
Quarterly	2021-06-30	12515000.0	+92.3%	USD	10-Q	2022-07-26
Quarterly	2021-09-30	19155000.0	+53.1%	USD	10-Q	2022-10-25
Quarterly	2022-03-31	9257000.0	-51.7%	USD	10-Q	2023-04-25
Quarterly	2022-06-30	20457000.0	+121.0%	USD	10-Q	2023-07-25
Quarterly	2022-09-30	27636000.0	+35.1%	USD	10-Q	2023-10-24
Quarterly	2023-03-31	9513000.0	-65.6%	USD	10-Q	2024-04-23
Quarterly	2023-06-30	17959000.0	+88.8%	USD	10-Q	2024-07-23
Quarterly	2023-09-30	26662000.0	+48.5%	USD	10-Q	2024-10-22
Quarterly	2024-03-31	5497000.0	-79.4%	USD	10-Q	2025-04-22
Quarterly	2024-06-30	18368000.0	+234.1%	USD	10-Q	2025-07-22
Quarterly	2024-09-30	28905000.0	+57.4%	USD	10-Q	2025-10-23
Quarterly	2025-03-31	9994000.0	-65.4%	USD	10-Q	2025-04-22
Quarterly	2025-06-30	16107000.0	+61.2%	USD	10-Q	2025-07-22
Quarterly	2025-09-30	26820000.0	+66.5%	USD	10-Q	2025-10-23
Annual	2016-12-31	13537000.0	—	USD	10-K	2019-02-26
Annual	2017-12-31	11724000.0	-13.4%	USD	10-K	2020-02-25
Annual	2018-12-31	16024000.0	+36.7%	USD	10-K	2021-02-16
Annual	2019-12-31	17912000.0	+11.8%	USD	10-K	2022-02-15
Annual	2020-12-31	31340000.0	+75.0%	USD	10-K	2023-02-14
Annual	2021-12-31	28271000.0	-9.8%	USD	10-K	2024-02-13
Annual	2022-12-31	36879000.0	+30.4%	USD	10-K	2025-02-11
Annual	2023-12-31	36648000.0	-0.6%	USD	10-K	2026-02-10
Annual	2024-12-31	36548000.0	-0.3%	USD	10-K	2026-02-10
Annual	2025-12-31	31356000.0	-14.2%	USD	10-K	2026-02-10

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	32625000.0	—	shares	10-Q	2017-05-02
Quarterly	2016-06-30	32828000.0	+0.6%	shares	10-Q	2017-08-01
Quarterly	2016-09-30	37623000.0	+14.6%	shares	10-Q	2017-10-31
Quarterly	2017-03-31	41508000.0	+10.3%	shares	10-Q	2018-05-01
Quarterly	2017-06-30	40825000.0	-1.6%	shares	10-Q	2018-07-31
Quarterly	2017-09-30	39329000.0	-3.7%	shares	10-Q	2018-10-30
Quarterly	2018-03-31	36449000.0	-7.3%	shares	10-Q	2019-04-30
Quarterly	2018-06-30	36664000.0	+0.6%	shares	10-Q	2019-07-30
Quarterly	2018-09-30	37125000.0	+1.3%	shares	10-Q	2019-10-29
Quarterly	2019-03-31	37285000.0	+0.4%	shares	10-Q	2020-04-29
Quarterly	2019-06-30	37389000.0	+0.3%	shares	10-Q	2020-07-28
Quarterly	2019-09-30	37835000.0	+1.2%	shares	10-Q	2020-10-27
Quarterly	2020-03-31	38030000.0	+0.5%	shares	10-Q	2021-04-27
Quarterly	2020-06-30	37328000.0	-1.8%	shares	10-Q	2021-07-27
Quarterly	2020-09-30	37763000.0	+1.2%	shares	10-Q	2021-10-26
Quarterly	2021-03-31	37749000.0	-0.0%	shares	10-Q	2022-04-26
Quarterly	2021-06-30	37714000.0	-0.1%	shares	10-Q	2022-07-26
Quarterly	2021-09-30	37519000.0	-0.5%	shares	10-Q	2022-10-25
Quarterly	2022-03-31	36364000.0	-3.1%	shares	10-Q	2023-04-25
Quarterly	2022-06-30	33695000.0	-7.3%	shares	10-Q	2023-07-25
Quarterly	2022-09-30	32253000.0	-4.3%	shares	10-Q	2023-10-24
Quarterly	2023-03-31	32155000.0	-0.3%	shares	10-Q	2024-04-23
Quarterly	2023-06-30	31575000.0	-1.8%	shares	10-Q	2024-07-23
Quarterly	2023-09-30	31762000.0	+0.6%	shares	10-Q	2024-10-22
Quarterly	2024-03-31	32001000.0	+0.8%	shares	10-Q	2025-04-22
Quarterly	2024-06-30	32086000.0	+0.3%	shares	10-Q	2025-07-22
Quarterly	2024-09-30	32088000.0	+0.0%	shares	10-Q	2025-10-23
Quarterly	2025-03-31	31196000.0	-2.8%	shares	10-Q	2025-04-22
Quarterly	2025-06-30	29143000.0	-6.6%	shares	10-Q	2025-07-22
Quarterly	2025-09-30	28817000.0	-1.1%	shares	10-Q	2025-10-23
Annual	2016-12-31	36329000.0	—	shares	10-K	2019-02-26
Annual	2017-12-31	39839000.0	+9.7%	shares	10-K	2020-02-25
Annual	2018-12-31	36912000.0	-7.3%	shares	10-K	2021-02-16
Annual	2019-12-31	37576000.0	+1.8%	shares	10-K	2022-02-15
Annual	2020-12-31	37708000.0	+0.4%	shares	10-K	2023-02-14
Annual	2021-12-31	37697000.0	-0.0%	shares	10-K	2024-02-13
Annual	2022-12-31	33671000.0	-10.7%	shares	10-K	2025-02-11
Annual	2023-12-31	31841000.0	-5.4%	shares	10-K	2026-02-10
Annual	2024-12-31	32014000.0	+0.5%	shares	10-K	2026-02-10
Annual	2025-12-31	29527000.0	-7.8%	shares	10-K	2026-02-10

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

Total Liabilities (latest annual)

1,516,401,000

Current Liabilities (latest annual)

1,343,748,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-09-30	0.0082	—	ratio	10-Q	2017-10-31
Quarterly	2017-03-31	0.0136	+64.9%	ratio	10-Q	2018-05-01
Quarterly	2017-06-30	0.0296	+117.9%	ratio	10-Q	2018-07-31
Quarterly	2017-09-30	0.0506	+70.7%	ratio	10-Q	2018-10-30
Quarterly	2018-03-31	0.0276	-45.4%	ratio	10-Q	2019-10-29
Quarterly	2018-06-30	0.0305	+10.4%	ratio	10-Q	2019-10-29
Quarterly	2018-09-30	0.0893	+192.9%	ratio	10-Q	2019-10-29
Quarterly	2019-03-31	0.0309	-65.4%	ratio	10-Q	2020-10-27
Quarterly	2019-06-30	0.0417	+35.2%	ratio	10-Q	2020-10-27
Quarterly	2019-09-30	0.1021	+144.6%	ratio	10-Q	2020-10-27
Quarterly	2020-03-31	0.0403	-60.5%	ratio	10-Q	2021-10-26
Quarterly	2020-06-30	0.0327	-19.0%	ratio	10-Q	2021-10-26
Quarterly	2020-09-30	0.1194	+265.6%	ratio	10-Q	2021-10-26
Quarterly	2021-03-31	0.0504	-57.8%	ratio	10-Q	2022-10-25
Quarterly	2021-06-30	0.0469	-7.0%	ratio	10-Q	2022-10-25
Quarterly	2021-09-30	0.0541	+15.4%	ratio	10-Q	2022-10-25
Quarterly	2022-03-31	0.1013	+87.4%	ratio	10-Q	2023-10-24
Quarterly	2022-06-30	0.1743	+72.0%	ratio	10-Q	2023-10-24
Quarterly	2022-09-30	0.1887	+8.3%	ratio	10-Q	2023-10-24
Quarterly	2023-03-31	0.2099	+11.2%	ratio	10-Q	2024-10-22
Quarterly	2023-06-30	0.1562	-25.6%	ratio	10-Q	2024-10-22
Quarterly	2023-09-30	0.1498	-4.1%	ratio	10-Q	2024-10-22
Quarterly	2024-03-31	0.1528	+2.0%	ratio	10-Q	2025-10-23
Quarterly	2024-06-30	0.1157	-24.3%	ratio	10-Q	2025-10-23
Quarterly	2024-09-30	0.1094	-5.5%	ratio	10-Q	2025-10-23
Quarterly	2025-03-31	0.1930	+76.5%	ratio	10-Q	2025-10-23
Quarterly	2025-06-30	0.5237	+171.3%	ratio	10-Q	2025-10-23
Quarterly	2025-09-30	0.3785	-27.7%	ratio	10-Q	2025-10-23
Annual	2016-12-31	0.0220	—	ratio	10-K	2019-02-26
Annual	2017-12-31	0.0768	+249.5%	ratio	10-K	2020-02-25
Annual	2018-12-31	0.1222	+59.1%	ratio	10-K	2021-02-16
Annual	2019-12-31	0.1383	+13.2%	ratio	10-K	2022-02-15
Annual	2020-12-31	0.1804	+30.5%	ratio	10-K	2023-02-14
Annual	2021-12-31	0.1908	+5.8%	ratio	10-K	2024-02-13
Annual	2022-12-31	0.6350	+232.8%	ratio	10-K	2025-02-11
Annual	2023-12-31	0.5060	-20.3%	ratio	10-K	2026-02-10
Annual	2024-12-31	0.4898	-3.2%	ratio	10-K	2026-02-10
Annual	2025-12-31	0.9827	+100.6%	ratio	10-K	2026-02-10

8-K Material Event Details

39 filings · 77 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

523 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	29	$0.00	$0	84
2026-03-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	29	—	—	10,324
2026-03-18	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	12,000	$0.00	$0	11,028
2026-03-18	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	12,000	$166.73	$2,000,760	70,484
2026-03-17	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	31,707	$0.00	$0	0
2026-03-17	GEIGER JESSE J	President	Open-market sell S	Common Stock	31,707	$455.30	$14,436,197	15,000
2026-03-17	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	31,707	$138.87	$4,403,151	46,707
2026-02-17	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,500	$0.00	$0	19,849
2026-02-17	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	3,500	$138.87	$486,045	16,843
2026-02-13	Carley Brian T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,472	$0.00	$0	0
2026-02-13	Carley Brian T	Dir	Exercise / conversion M	Common Stock	6,472	$54.99	$355,895	32,753
2025-12-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	49	$0.00	$0	0
2025-12-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	49	—	—	10,295
2025-12-05	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	10,984
2025-12-05	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	10,000	$107.93	$1,079,300	47,500
2025-12-03	Troendle August J.	CEO	Open-market sell S	Common Stock	668	$590.69	$394,581	646,184
2025-12-02	Troendle August J.	CEO	Open-market sell S	Common Stock	5,698	$590.47	$3,364,498	646,852
2025-12-02	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	20,984
2025-12-02	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	10,000	$107.93	$1,079,300	37,500
2025-12-01	Troendle August J.	CEO	Open-market sell S	Common Stock	23,178	$593.25	$13,750,348	652,550
2025-11-28	Troendle August J.	CEO	Open-market sell S	Common Stock	15,151	$593.46	$8,991,512	675,728
2025-11-28	McCarthy Cornelius P. III	Dir	Equity grant / award A · derivative	Restricted Stock Unit	113	$592.46	$66,948	113
2025-11-26	Troendle August J.	CEO	Open-market sell S	Common Stock	41,331	$606.88	$25,082,957	690,879
2025-11-25	Troendle August J.	CEO	Open-market sell S	Common Stock	42,392	$615.52	$26,093,124	732,210
2025-11-24	Troendle August J.	CEO	Open-market sell S	Common Stock	59,025	$607.78	$35,874,214	774,602
2025-11-21	Troendle August J.	CEO	Open-market sell S	Common Stock	21,858	$592.18	$12,943,870	833,627
2025-11-21	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,000	$0.00	$0	0
2025-11-21	Brady Kevin M.	CFO & Treasurer	Equity grant / award G	Common Stock	170	$0.00	$0	5,830
2025-11-21	Brady Kevin M.	CFO & Treasurer	Open-market sell S	Common Stock	3,000	$590.35	$1,771,050	6,000
2025-11-21	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M	Common Stock	3,000	$166.73	$500,190	9,000
2025-11-20	Troendle August J.	CEO	Open-market sell S	Common Stock	6,830	$598.49	$4,087,687	855,485
2025-11-19	Troendle August J.	CEO	Open-market sell S	Common Stock	23,862	$592.07	$14,127,974	862,315
2025-11-18	Troendle August J.	CEO	Open-market sell S	Common Stock	7,191	$590.84	$4,248,730	886,177
2025-11-14	Kraft Robert O.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,472	$0.00	$0	0
2025-11-14	Kraft Robert O.	Dir	Open-market sell S	Common Stock	6,472	$591.85	$3,830,453	833
2025-11-14	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	6,472	$54.99	$355,895	7,305
2025-11-13	Troendle August J.	CEO	Open-market sell S	Common Stock	5,128	$601.37	$3,083,825	914,162
2025-11-12	Troendle August J.	CEO	Open-market sell S	Common Stock	5,312	$603.23	$3,204,358	919,290
2025-11-11	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	18,000	$605.00	$10,890,000	47,500
2025-11-05	GEIGER JESSE J	President	Open-market sell S	Common Stock	21,503	$595.66	$12,808,477	15,000
2025-10-30	DAVENPORT FRED B JR	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,472	$0.00	$0	0
2025-10-30	DAVENPORT FRED B JR	Dir	Open-market sell S	Common Stock	5,972	$581.88	$3,474,987	3,498
2025-10-30	DAVENPORT FRED B JR	Dir	Exercise / conversion M	Common Stock	6,472	$54.99	$355,895	9,470
2025-10-29	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,568	$0.00	$0	0
2025-10-29	GEIGER JESSE J	President	Open-market sell S	Common Stock	3,568	$585.00	$2,087,280	36,503
2025-10-29	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	3,568	$166.73	$594,893	40,071
2025-10-27	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	19,460	$0.00	$0	3,568
2025-10-27	GEIGER JESSE J	President	Open-market sell S	Common Stock	19,460	$605.12	$11,775,635	36,503
2025-10-27	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	19,460	$166.73	$3,244,566	55,963
2025-09-30	Kraft Robert O.	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	57	$0.00	$0	56
2025-09-30	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	57	—	—	833
2025-09-26	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	30,984
2025-09-26	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	10,000	$107.93	$1,079,300	67,500
2025-09-03	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	10,000	$480.00	$4,800,000	57,500
2025-09-02	Troendle August J.	CEO	Open-market sell S	Common Stock	1,197	$475.11	$568,707	924,602
2025-08-29	Troendle August J.	CEO	Open-market sell S	Common Stock	36,196	$475.90	$17,225,676	925,799
2025-08-27	Troendle August J.	CEO	Open-market sell S	Common Stock	620	$475.00	$294,500	961,995
2025-08-26	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	40,984
2025-08-26	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	10,000	$107.93	$1,079,300	67,500
2025-08-19	McCarthy Cornelius P. III	Dir	Open-market sell S	Common Stock	1,662	$465.04	$772,896	10,197
2025-07-28	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	3,000	$450.00	$1,350,000	10,343
2025-07-24	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	41,801	$0.00	$0	0
2025-07-24	GEIGER JESSE J	President	Open-market sell S	Common Stock	41,801	$453.11	$18,940,451	36,503
2025-07-24	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	41,801	$107.93	$4,511,582	78,304
2025-07-22	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,972	$0.00	$0	0
2025-07-22	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	1,972	$54.99	$108,440	11,859
2025-07-18	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,500	$0.00	$0	1,972
2025-07-18	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	4,500	$54.99	$247,455	9,887
2025-06-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	50	$0.00	$0	98
2025-06-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	50	—	—	5,387
2025-05-16	Zander Dani S.	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,224	$0.00	$0	1,224
2025-04-24	DAVENPORT FRED B JR	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,710	$0.00	$0	0
2025-04-24	DAVENPORT FRED B JR	Dir	Open-market sell S	Common Stock	1,712	$301.82	$516,716	2,998
2025-04-24	DAVENPORT FRED B JR	Dir	Exercise / conversion M	Common Stock	4,710	$57.17	$269,271	4,710
2025-03-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	50	$0.00	$0	148
2025-03-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	50	—	—	5,337
2025-03-07	Troendle August J.	CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	84,770	$0.00	$0	0
2025-03-07	Troendle August J.	CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	234,259	$0.00	$0	0
2025-03-07	Troendle August J.	CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	37,417	$0.00	$0	0
2025-03-07	Troendle August J.	CEO	Exercise / conversion M	Common Stock	84,770	$107.93	$9,149,226	1,011,102
2025-03-07	Troendle August J.	CEO	Exercise / conversion M	Common Stock	234,259	$56.61	$13,261,402	926,332
2025-03-07	Troendle August J.	CEO	Exercise / conversion M	Common Stock	37,417	$54.74	$2,048,207	692,073
2025-03-06	Troendle August J.	CEO	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	73,443	$0.00	$0	73,443
2025-02-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market buy P	Common Stock	2	$326.11	$652	13,343
2025-02-24	Carley Brian T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	8,127	$0.00	$0	0
2025-02-24	Carley Brian T	Dir	Open-market sell S	Common Stock	4,003	$345.59	$1,383,397	26,032
2025-02-24	Carley Brian T	Dir	Exercise / conversion M	Common Stock	8,127	$42.62	$346,373	30,035
2024-12-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	62	$0.00	$0	0
2024-12-31	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	62	—	—	5,287
2024-12-06	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	15,000	$0.00	$0	0
2024-12-06	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	15,000	$32.05	$480,750	36,503
2024-11-29	McCarthy Cornelius P. III	Dir	Equity grant / award A · derivative	Restricted Stock Unit	198	$340.63	$67,445	198
2024-11-19	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,500	$0.00	$0	0
2024-11-19	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	7,500	$32.05	$240,375	65,000
2024-09-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	62	$0.00	$0	62
2024-09-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	62	—	—	5,225
2024-08-23	Kraft Robert O.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	3,774	$0.00	$0	0
2024-08-23	Kraft Robert O.	Dir	Open-market sell S	Common Stock	3,774	$390.73	$1,474,615	520
2024-08-23	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	3,774	$42.62	$160,848	4,294
2024-08-22	Kraft Robert O.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,353	$0.00	$0	3,774
2024-08-22	Kraft Robert O.	Dir	Open-market sell S	Common Stock	4,353	$390.73	$1,700,848	520
2024-08-22	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	4,353	$42.62	$185,525	4,873
2024-08-05	BURWIG SUSAN E	Exec. VP, Operations	Equity grant / award A · derivative	Restricted Stock Unit	10,000	$0.00	$0	10,000
2024-08-05	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	50,000	$0.00	$0	0
2024-08-05	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	50,000	$90.65	$4,532,500	57,500
2024-07-01	Zander Dani S.	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	824	$0.00	$0	824
2024-06-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	62	$0.00	$0	124
2024-06-30	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	62	—	—	5,163
2024-06-05	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	7,681	$401.20	$3,081,617	7,500
2024-05-28	Troendle August J.	CEO	Open-market sell S	Common Stock	5,695	$395.49	$2,252,316	654,656
2024-05-24	Troendle August J.	CEO	Open-market sell S	Common Stock	3,987	$395.22	$1,575,742	660,351
2024-05-22	Troendle August J.	CEO	Open-market sell S	Common Stock	55	$400.00	$22,000	664,338
2024-05-20	Troendle August J.	CEO	Open-market sell S	Common Stock	4,020	$400.19	$1,608,764	664,393
2024-05-17	McCarthy Cornelius P. III	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	953	$0.00	$0	953
2024-05-16	Troendle August J.	CEO	Open-market sell S	Common Stock	7,060	$403.09	$2,845,815	668,413
2024-05-15	Troendle August J.	CEO	Open-market sell S	Common Stock	32,282	$405.13	$13,078,407	675,473
2024-05-10	Troendle August J.	CEO	Open-market sell S	Common Stock	4,956	$402.89	$1,996,723	707,755
2024-05-09	Troendle August J.	CEO	Open-market sell S	Common Stock	3,486	$400.17	$1,394,993	712,711
2024-05-08	Troendle August J.	CEO	Open-market sell S	Common Stock	4,782	$400.58	$1,915,574	716,197
2024-05-07	Troendle August J.	CEO	Open-market sell S	Common Stock	28,032	$404.48	$11,338,383	720,979
2024-05-06	Troendle August J.	CEO	Open-market sell S	Common Stock	24,372	$401.73	$9,790,964	749,011
2024-05-02	Troendle August J.	CEO	Open-market sell S	Common Stock	3,396	$400.44	$1,359,894	773,383
2024-05-01	Troendle August J.	CEO	Open-market sell S	Common Stock	12,934	$401.56	$5,193,777	776,779
2024-04-30	Troendle August J.	CEO	Open-market sell S	Common Stock	1,828	$400.31	$731,767	789,713
2024-04-29	Troendle August J.	CEO	Open-market sell S	Common Stock	15,102	$400.69	$6,051,220	791,541
2024-03-31	Kraft Robert O.	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	72	$0.00	$0	214
2024-03-31	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	72	—	—	448
2024-03-15	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	102	$403.00	$41,106	15,181
2024-03-14	Keating Ashley M.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	500	$0.00	$0	3,358
2024-03-14	Keating Ashley M.	Dir	Open-market sell S	Common Stock	250	$409.87	$102,468	250
2024-03-14	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	500	$84.36	$42,180	500
2024-03-08	Troendle August J.	CEO	Open-market sell S	Common Stock	25,000	$408.71	$10,217,750	4,733,019
2024-03-07	Troendle August J.	CEO	Open-market sell S	Common Stock	75,000	$410.74	$30,805,500	4,758,019
2024-03-07	Keating Ashley M.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	472	$0.00	$0	0
2024-03-07	Keating Ashley M.	Dir	Open-market sell S	Common Stock	472	$415.00	$195,880	0
2024-03-07	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	472	$54.99	$25,955	472
2024-03-06	Troendle August J.	CEO	Open-market sell S	Common Stock	100,000	$412.98	$41,298,000	4,833,019
2024-03-05	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	17,679	$0.00	$0	0
2024-03-05	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	17,679	$90.65	$1,602,601	21,503
2024-03-04	GEIGER JESSE J	President	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	22,321	$0.00	$0	17,679
2024-03-04	GEIGER JESSE J	President	Open-market sell S	Common Stock	22,321	$403.03	$8,996,033	3,824
2024-03-04	GEIGER JESSE J	President	Exercise / conversion M	Common Stock	22,321	$90.65	$2,023,399	26,145
2024-03-01	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	80,000	$401.88	$32,150,400	5,033,019
2024-02-29	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	20,000	$393.71	$7,874,200	5,113,019
2024-02-28	Troendle August J.	CEO	Open-market sell S	Common Stock	50,000	$404.13	$20,206,500	5,133,019
2024-02-28	Keating Ashley M.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	500	$0.00	$0	472
2024-02-28	Keating Ashley M.	Dir	Open-market sell S	Common Stock	500	$405.00	$202,500	0
2024-02-28	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	500	$54.99	$27,495	500
2024-02-27	Troendle August J.	CEO	Open-market sell S	Common Stock	50,000	$401.88	$20,094,000	5,183,019
2024-02-26	Troendle August J.	CEO	Open-market sell S	Common Stock	56,928	$402.38	$22,906,689	5,233,019
2024-02-26	Keating Ashley M.	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	500	$0.00	$0	972
2024-02-26	Keating Ashley M.	Dir	Open-market sell S	Common Stock	254	$404.68	$102,789	0
2024-02-26	Keating Ashley M.	Dir	Open-market sell S	Common Stock	246	$403.89	$99,358	254
2024-02-26	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	500	$54.99	$27,495	500
2024-02-23	Troendle August J.	CEO	Open-market sell S	Common Stock	100,000	$400.32	$40,032,000	5,289,947
2024-02-22	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	100,000	$395.98	$39,598,000	5,389,947
2024-02-21	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	36,012	$383.44	$13,808,441	5,489,947
2024-02-20	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	13,988	$386.39	$5,404,823	5,525,959
2024-02-20	Carley Brian T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	13,782	$0.00	$0	0
2024-02-20	Carley Brian T	Dir	Exercise / conversion M	Common Stock	13,782	$26.44	$364,396	21,595
2024-02-16	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	50,000	$391.75	$19,587,500	5,539,947
2024-02-08	McCarthy Cornelius P. III	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,710	$0.00	$0	0
2024-02-08	McCarthy Cornelius P. III	Dir	Exercise / conversion M	Common Stock	4,710	$57.17	$269,271	5,038
2023-12-31	Kraft Robert O.	—	Exercise / conversion M · derivative	Restricted Stock Unit	94	$0.00	$0	0
2023-12-31	Kraft Robert O.	—	Exercise / conversion M	Common Stock	94	—	—	376
2023-12-15	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	2,009	$303.00	$608,727	15,283
2023-12-14	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	10,391	$304.15	$3,160,423	17,292
2023-12-01	Troendle August J.	CEO	Open-market sell S	Common Stock	24,039	$273.26	$6,568,897	5,589,947
2023-11-30	Troendle August J.	CEO	Open-market sell S	Common Stock	7,871	$272.18	$2,142,329	5,613,986
2023-11-30	McCarthy Cornelius P. III	—	Equity grant / award A · derivative	Restricted Stock Unit	249	$270.72	$67,409	249
2023-11-29	Troendle August J.	CEO	Open-market sell S	Common Stock	18,090	$272.62	$4,931,696	5,621,857
2023-11-29	Troendle August J.	CEO	Open-market sell S	Common Stock	3,167	$272.87	$864,179	5,639,947
2023-11-28	Medpace Investors, LLC	—	Open-market sell S	Common Stock	21,833	$273.66	$5,974,819	5,643,114
2023-11-27	Medpace Investors, LLC	—	Open-market sell S	Common Stock	25,000	$276.10	$6,902,500	5,664,947
2023-11-22	Troendle August J.	CEO	Open-market sell S	Common Stock	25,000	$277.81	$6,945,250	5,689,947
2023-11-21	Medpace Investors, LLC	—	Open-market sell S	Common Stock	25,000	$277.37	$6,934,250	5,714,947
2023-11-20	Medpace Investors, LLC	—	Open-market sell S	Common Stock	50,000	$275.45	$13,772,500	5,739,947
2023-11-17	Medpace Investors, LLC	—	Open-market sell S	Common Stock	50,000	$273.91	$13,695,500	5,789,947
2023-11-16	Troendle August J.	CEO	Open-market sell S	Common Stock	17,000	$281.61	$4,787,370	5,839,947
2023-11-15	Troendle August J.	CEO	Open-market sell S	Common Stock	33,000	$283.42	$9,352,860	5,856,947
2023-11-14	Troendle August J.	CEO	Open-market sell S	Common Stock	25,000	$283.11	$7,077,750	5,889,947
2023-10-23	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,500	$0.00	$0	7,500
2023-10-23	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	7,500	$32.05	$240,375	27,683
2023-09-30	Carley Brian T	—	Exercise / conversion M · derivative	Restricted Stock Unit	103	$0.00	$0	103
2023-09-30	Carley Brian T	—	Exercise / conversion M	Common Stock	103	—	—	7,710
2023-09-21	Troendle August J.	CEO	Open-market sell S	Common Stock	61,655	$244.27	$15,060,467	5,914,947
2023-09-20	Troendle August J.	CEO	Open-market sell S	Common Stock	65,653	$255.48	$16,773,028	5,976,602
2023-09-19	Medpace Investors, LLC	—	Open-market sell S	Common Stock	137,379	$259.66	$35,671,831	6,042,255
2023-09-18	Medpace Investors, LLC	—	Open-market sell S	Common Stock	53,385	$274.76	$14,668,063	6,179,634
2023-08-14	Kraft Robert O.	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	13,782	$0.00	$0	0
2023-08-14	Kraft Robert O.	—	Open-market sell S	Common Stock	13,782	$265.67	$3,661,464	188
2023-08-14	Kraft Robert O.	—	Exercise / conversion M	Common Stock	13,782	$26.44	$364,396	13,970
2023-07-31	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	0
2023-07-31	Brady Kevin M.	CFO & Treasurer	Open-market sell S	Common Stock	7,000	$255.00	$1,785,000	6,000
2023-07-31	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M	Common Stock	10,000	$90.65	$906,500	13,000
2023-07-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	21,850	$0.00	$0	0
2023-07-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	21,850	$254.39	$5,558,422	14,854
2023-07-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	21,850	$107.93	$2,358,270	36,704
2023-06-30	Kraft Robert O.	—	Exercise / conversion M · derivative	Restricted Stock Unit	94	$0.00	$0	188
2023-06-30	Kraft Robert O.	—	Exercise / conversion M	Common Stock	94	—	—	188
2023-06-15	Carley Brian T	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,400	$0.00	$0	0
2023-06-15	Carley Brian T	—	Exercise / conversion M	Common Stock	7,400	$23.00	$170,200	7,504
2023-06-08	Troendle August J.	CEO	Open-market sell S	Common Stock	49,347	$220.85	$10,898,285	6,233,019
2023-06-07	Troendle August J.	CEO	Open-market sell S	Common Stock	110,324	$223.05	$24,607,768	6,282,366
2023-06-06	Troendle August J.	CEO	Open-market sell S	Common Stock	58,681	$220.46	$12,936,813	6,392,690
2023-05-19	Carley Brian T	—	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,769	$0.00	$0	1,769
2023-04-25	Troendle August J.	CEO	Open-market sell S	Common Stock	31,648	$221.83	$7,020,476	6,451,371
2023-03-31	Kraft Robert O.	—	Exercise / conversion M · derivative	Restricted Stock Unit	94	$0.00	$0	282
2023-03-31	Kraft Robert O.	—	Exercise / conversion M	Common Stock	94	—	—	94
2023-02-17	EWALD STEPHEN P	General Counsel & Corp. Secy.	Equity grant / award A · derivative	Restricted Stock Unit	1,000	$0.00	$0	1,000
2023-01-16	Gwadry-Sridhar Femida H.	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	573	$0.00	$0	573
2022-12-09	Kraft Robert O.	Dir	Equity grant / award A · derivative	Restricted Stock Unit	376	$205.77	$77,370	376
2022-11-16	Brady Kevin M.	CFO & Treasurer	Open-market sell S	Common Stock	344	$227.09	$78,119	3,000
2022-11-15	Brady Kevin M.	CFO & Treasurer	Open-market sell S	Common Stock	1,656	$229.30	$379,721	3,344
2022-11-01	Kraft Robert O.	Dir	Exercise / conversion M · derivative	STOCK OPTION (RIGHT TO BUY)	9,630	$0.00	$0	0
2022-11-01	Kraft Robert O.	Dir	Open-market sell S	Common Stock	9,630	$221.42	$2,132,275	0
2022-11-01	Kraft Robert O.	Dir	Exercise / conversion M	Common Stock	9,630	$23.00	$221,490	9,630
2022-10-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	6,500	$0.00	$0	0
2022-10-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	6,500	$220.53	$1,433,445	14,854
2022-10-27	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	6,500	$32.05	$208,325	21,354
2022-09-22	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	57,426	$154.59	$8,877,485	6,483,019
2022-09-21	Troendle August J.	CEO	Open-market buy P	Common Stock	94,119	$161.63	$15,212,454	6,425,593
2022-09-20	Troendle August J.	CEO	Open-market buy P	Common Stock	94,119	$155.14	$14,601,622	6,331,474
2022-09-19	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	94,119	$153.48	$14,445,384	6,237,355
2022-09-16	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	62,516	$149.58	$9,351,143	6,143,236
2022-09-15	Troendle August J.	CEO	Open-market buy P	Common Stock	62,516	$153.11	$9,571,825	6,080,720
2022-09-14	Troendle August J.	CEO	Open-market buy P	Common Stock	62,516	$152.66	$9,543,693	6,018,204
2022-09-13	Troendle August J.	CEO	Open-market buy P	Common Stock	62,516	$157.12	$9,822,514	5,955,688
2022-09-12	Troendle August J.	CEO	Open-market buy P	Common Stock	62,515	$167.58	$10,476,264	5,893,172
2022-09-09	Troendle August J.	CEO	Open-market buy P	Common Stock	56,557	$164.33	$9,294,012	5,830,657
2022-09-08	Troendle August J.	CEO	Open-market buy P	Common Stock	56,557	$157.65	$8,916,211	5,774,100
2022-09-07	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	56,557	$150.72	$8,524,271	5,717,543
2022-09-06	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	56,557	$147.59	$8,347,248	5,660,986
2022-09-02	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	48,714	$144.98	$7,062,556	5,604,429
2022-09-01	Medpace Investors, LLC	10%	Open-market buy P	Common Stock	42,076	$144.52	$6,080,824	5,555,715
2022-07-18	Troendle August J.	CEO	Open-market buy P	Common Stock	8,330	$145.00	$1,207,850	5,513,639
2022-07-14	Troendle August J.	CEO	Open-market buy P	Common Stock	22,290	$144.59	$3,222,911	5,505,309
2022-05-20	Carley Brian T	Dir	Equity grant / award A · derivative	STOCK OPTION (RIGHT TO BUY)	1,903	$0.00	$0	1,903
2022-05-06	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,000	$0.00	$0	6,500
2022-05-06	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	1,000	$32.05	$32,050	14,854
2022-03-01	Troendle August J.	CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	100,000	$0.00	$0	0
2022-03-01	Troendle August J.	CEO	Exercise / conversion M	Common Stock	100,000	$90.65	$9,065,000	806,643
2022-02-23	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	12,400	$0.00	$0	0
2022-02-23	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	12,400	$28.32	$351,168	20,183
2022-02-17	DAVENPORT FRED B JR	Dir	Open-market buy P	Common Stock	500	$145.80	$72,900	2,000
2022-02-15	Brady Kevin M.	CFO & Treasurer	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	13,803	$0.00	$0	13,803
2022-01-04	Troendle August J.	CEO	Open-market sell S	Common Stock	3,338	$213.44	$712,463	5,483,019
2022-01-03	Troendle August J.	CEO	Open-market sell S	Common Stock	19,744	$212.70	$4,199,549	5,486,357
2021-12-31	Troendle August J.	CEO	Open-market sell S	Common Stock	13,069	$219.14	$2,863,941	5,506,101
2021-12-30	Troendle August J.	CEO	Open-market sell S	Common Stock	17,376	$220.34	$3,828,628	5,519,170
2021-12-29	Troendle August J.	CEO	Open-market sell S	Common Stock	16,750	$220.16	$3,687,680	5,536,546
2021-12-28	Troendle August J.	CEO	Open-market sell S	Common Stock	24,118	$222.18	$5,358,537	5,553,296
2021-12-27	Troendle August J.	CEO	Open-market sell S	Common Stock	39,171	$226.11	$8,856,955	5,577,414
2021-12-23	Troendle August J.	CEO	Open-market sell S	Common Stock	22,830	$223.19	$5,095,428	5,616,585
2021-12-22	Troendle August J.	CEO	Open-market sell S	Common Stock	38,960	$220.50	$8,590,680	5,639,415
2021-12-21	Troendle August J.	CEO	Open-market sell S	Common Stock	18,133	$215.17	$3,901,678	5,678,375
2021-12-20	Troendle August J.	CEO	Open-market sell S	Common Stock	22,734	$212.57	$4,832,566	5,696,508
2021-12-17	Troendle August J.	CEO	Open-market sell S	Common Stock	30,605	$213.59	$6,536,922	5,719,242
2021-12-16	Troendle August J.	CEO	Open-market sell S	Common Stock	5,959	$210.22	$1,252,701	5,749,847
2021-12-15	Troendle August J.	CEO	Open-market sell S	Common Stock	2,424	$210.28	$509,719	5,755,806
2021-12-10	Troendle August J.	CEO	Open-market sell S	Common Stock	309	$210.20	$64,952	5,758,230
2021-12-09	Troendle August J.	CEO	Open-market sell S	Common Stock	14,994	$212.13	$3,180,677	5,758,539
2021-12-08	Troendle August J.	CEO	Open-market sell S	Common Stock	15,871	$212.89	$3,378,777	5,773,533
2021-12-07	Troendle August J.	CEO	Open-market sell S	Common Stock	18,520	$211.78	$3,922,166	5,789,404
2021-12-03	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	400	$211.48	$84,592	5,807,924
2021-12-02	Troendle August J.	CEO	Open-market sell S	Common Stock	6,090	$210.79	$1,283,711	5,808,324
2021-12-01	Troendle August J.	CEO	Open-market sell S	Common Stock	26,642	$211.57	$5,636,648	5,814,414
2021-11-30	Troendle August J.	CEO	Open-market sell S	Common Stock	197	$210.29	$41,427	5,841,056
2021-11-29	Troendle August J.	CEO	Open-market sell S	Common Stock	12,115	$212.10	$2,569,592	5,841,253
2021-11-26	Troendle August J.	CEO	Open-market sell S	Common Stock	15,071	$210.99	$3,179,830	5,853,368
2021-11-24	Troendle August J.	CEO	Open-market sell S	Common Stock	14,578	$213.26	$3,108,904	5,868,439
2021-11-23	Troendle August J.	CEO	Open-market sell S	Common Stock	26,057	$212.64	$5,540,760	5,883,017
2021-11-22	Troendle August J.	CEO	Open-market sell S	Common Stock	48,128	$224.33	$10,796,554	5,909,074
2021-11-03	King Tom C	Dir	Exercise / conversion M · derivative	STOCK OPTION (RIGHT TO BUY)	500	$0.00	$0	2,021
2021-11-03	King Tom C	Dir	Open-market sell S	Common Stock	176	$226.63	$39,887	598
2021-11-03	King Tom C	Dir	Exercise / conversion M	Common Stock	500	$75.63	$37,815	774
2021-11-02	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,250	$0.00	$0	10,000
2021-11-02	Brady Kevin M.	CFO & Treasurer	Open-market sell S	Common Stock	1,250	$226.50	$283,125	5,000
2021-11-02	Brady Kevin M.	CFO & Treasurer	Exercise / conversion M	Common Stock	1,250	$90.65	$113,312	6,250
2021-10-26	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	0
2021-10-26	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	10,000	$209.13	$2,091,300	13,854
2021-10-26	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	10,000	$90.65	$906,500	23,854
2021-09-03	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	7,185	$192.67	$1,384,334	7,783
2021-09-03	Keating Ashley M.	Dir	Exercise / conversion M · derivative	STOCK OPTION (RIGHT TO BUY)	2,000	$0.00	$0	3,472
2021-09-03	Keating Ashley M.	Dir	Open-market sell S	Common Stock	2,000	$195.00	$390,000	0
2021-09-03	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	2,000	$54.99	$109,980	2,000
2021-09-02	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	55,037	$192.16	$10,575,910	14,968
2021-09-01	Troendle August J.	CEO	Open-market sell S	Common Stock	14,304	$186.29	$2,664,692	5,988,040
2021-08-31	Troendle August J.	CEO	Open-market sell S	Common Stock	12,675	$182.04	$2,307,357	6,002,344
2021-08-30	Troendle August J.	CEO	Open-market sell S	Common Stock	12,236	$183.14	$2,240,901	6,015,019
2021-08-27	Troendle August J.	CEO	Open-market sell S	Common Stock	11,840	$181.83	$2,152,867	6,027,255
2021-08-26	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	466	$180.17	$83,959	6,039,095
2021-08-25	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	7,622	$180.54	$1,376,076	6,039,561
2021-08-24	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	1,814	$180.06	$326,629	6,047,183
2021-08-23	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	1,482	$180.22	$267,086	6,048,997
2021-08-18	Troendle August J.	CEO	Open-market sell S	Common Stock	2,301	$180.49	$415,307	6,050,479
2021-08-17	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	5,246	$182.10	$955,297	6,052,780
2021-08-16	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	16,817	$182.83	$3,074,652	6,058,026
2021-08-05	Troendle August J.	CEO	Open-market sell S	Common Stock	556	$180.04	$100,102	6,074,843
2021-08-04	Keating Ashley M.	Dir	Exercise / conversion M · derivative	STOCK OPTION (RIGHT TO BUY)	1,000	$0.00	$0	5,472
2021-08-04	Keating Ashley M.	Dir	Open-market sell S	Common Stock	1,000	$178.00	$178,000	0
2021-08-04	Keating Ashley M.	Dir	Exercise / conversion M	Common Stock	1,000	$54.99	$54,990	1,000
2021-07-29	King Tom C	Dir	Exercise / conversion M · derivative	STOCK OPTION (RIGHT TO BUY)	500	$0.00	$0	2,521
2021-07-29	King Tom C	Dir	Open-market sell S	Common Stock	226	$175.74	$39,717	274
2021-07-29	King Tom C	Dir	Exercise / conversion M	Common Stock	500	$75.63	$37,815	500
2021-07-27	Troendle August J.	President & CEO	Open-market sell S	Common Stock	131	$180.93	$23,702	6,075,399
2021-07-26	Troendle August J.	President & CEO	Open-market sell S	Common Stock	15,209	$181.47	$2,759,977	6,075,530
2021-07-23	Troendle August J.	President & CEO	Open-market sell S	Common Stock	18,882	$181.21	$3,421,607	6,090,739
2021-07-22	Troendle August J.	President & CEO	Open-market sell S	Common Stock	8,516	$180.63	$1,538,245	6,109,621
2021-07-21	Troendle August J.	President & CEO	Open-market sell S	Common Stock	9,206	$182.42	$1,679,359	6,118,137
2021-07-20	Troendle August J.	President & CEO	Open-market sell S	Common Stock	10,176	$183.06	$1,862,819	6,127,343
2021-07-19	Troendle August J.	President & CEO	Open-market sell S	Common Stock	1,442	$181.11	$261,161	6,137,519
2021-07-16	Troendle August J.	President & CEO	Open-market sell S	Common Stock	12,454	$182.83	$2,276,965	6,138,961
2021-07-15	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	13,697	$181.88	$2,491,210	6,151,415
2021-07-14	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	11,026	$182.63	$2,013,678	6,165,112
2021-07-13	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	13,050	$182.96	$2,387,628	6,176,138
2021-07-12	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	10,540	$183.22	$1,931,139	6,189,188
2021-07-09	Troendle August J.	President & CEO	Open-market sell S	Common Stock	12,597	$183.34	$2,309,534	6,199,728
2021-07-08	Troendle August J.	President & CEO	Open-market sell S	Common Stock	3,951	$180.18	$711,891	6,212,325
2021-07-07	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	4,574	$180.33	$824,829	6,216,276
2021-07-06	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	4,729	$180.58	$853,963	6,220,850
2021-07-02	Troendle August J.	President & CEO	Open-market sell S	Common Stock	3,556	$180.16	$640,649	6,225,579
2021-07-01	Troendle August J.	President & CEO	Open-market sell S	Common Stock	238	$180.03	$42,847	6,229,135
2021-06-29	Troendle August J.	President & CEO	Open-market sell S	Common Stock	4,926	$181.11	$892,148	6,229,373
2021-06-28	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	8,225	$181.15	$1,489,959	6,234,299
2021-06-25	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	10,846	$180.56	$1,958,354	6,242,524
2021-06-23	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	1,837	$180.79	$332,111	6,253,370
2021-06-22	Troendle August J.	President & CEO	Open-market sell S	Common Stock	12,133	$182.31	$2,211,967	6,255,207
2021-06-21	Troendle August J.	President & CEO	Open-market sell S	Common Stock	9,345	$181.86	$1,699,482	6,267,340
2021-06-18	Troendle August J.	President & CEO	Open-market sell S	Common Stock	1,261	$180.43	$227,522	6,276,685
2021-06-17	Troendle August J.	President & CEO	Open-market sell S	Common Stock	8,927	$181.20	$1,617,572	6,277,946
2021-06-16	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	17,413	$181.13	$3,154,017	6,286,873
2021-06-15	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	15,706	$182.00	$2,858,492	6,304,286
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,600	$0.00	$0	12,400
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,400	$0.00	$0	0
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	7,600	$178.90	$1,359,648	70,005
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	7,600	$28.32	$215,232	77,605
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	7,400	$179.02	$1,324,718	70,005
2021-06-14	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	7,400	$23.00	$170,200	77,405
2021-05-14	DAVENPORT FRED B JR	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,822	$0.00	$0	1,822
2021-04-27	BURWIG SUSAN E	Exec. VP, Operations	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	23,028	$0.00	$0	23,028
2021-04-26	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	20,729	$193.38	$4,008,574	6,319,992
2021-04-23	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	7,805	$190.51	$1,486,931	6,340,721
2021-04-22	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	14,377	$188.64	$2,712,077	6,348,526
2021-04-21	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	15,687	$187.02	$2,933,783	6,362,903
2021-04-20	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	17,623	$182.44	$3,215,140	6,378,590
2021-04-19	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	8,471	$180.90	$1,532,404	6,396,213
2021-04-16	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	17,528	$180.30	$3,160,298	6,404,684
2021-04-15	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	31,270	$186.65	$5,836,546	6,422,212
2021-04-14	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	3,720	$180.48	$671,386	6,453,482
2021-03-03	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	6,211	$167.00	$1,037,237	70,005
2021-02-10	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,000	$0.00	$0	0
2021-02-10	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	4,000	$160.00	$640,000	6,382
2021-02-10	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M	Common Stock	4,000	$23.00	$92,000	10,382
2021-02-09	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	10,000
2021-02-09	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	10,000	$155.48	$1,554,800	13,854
2021-02-09	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	10,000	$90.65	$906,500	23,854
2021-01-08	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	26,666	$140.71	$3,752,173	6,457,202
2021-01-07	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	93,552	$140.06	$13,102,893	6,483,868
2021-01-06	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	91,667	$140.06	$12,838,880	6,577,420
2021-01-04	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	10,127	$140.01	$1,417,881	6,483,740
2020-12-30	Troendle August J.	President & CEO	Open-market sell S	Common Stock	19,930	$140.01	$2,790,399	6,493,867
2020-12-28	Troendle August J.	President & CEO	Open-market sell S	Common Stock	1,374	$140.00	$192,360	6,513,797
2020-12-24	Troendle August J.	President & CEO	Open-market sell S	Common Stock	3,829	$140.00	$536,060	6,515,171
2020-12-23	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	40,000	$0.00	$0	37,417
2020-12-23	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	40,000	$54.74	$2,189,600	706,643
2020-12-23	Troendle August J.	President & CEO	Open-market sell S	Common Stock	3,547	$140.11	$496,970	6,519,000
2020-12-22	Troendle August J.	President & CEO	Open-market sell S	Common Stock	33,260	$140.01	$4,656,733	6,522,547
2020-12-18	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	216,048	$141.85	$30,646,409	6,555,807
2020-12-14	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,200	$0.00	$0	4,000
2020-12-14	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	4,200	$142.00	$596,400	6,382
2020-12-14	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M	Common Stock	4,200	$23.00	$96,600	10,582
2020-12-10	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,000	$0.00	$0	20,000
2020-12-10	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	10,000	$140.07	$1,400,700	13,854
2020-12-10	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	10,000	$90.65	$906,500	23,854
2020-12-01	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	14,000	$130.86	$1,832,040	6,771,855
2020-11-06	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	10,518	$0.00	$0	0
2020-11-06	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	10,518	$14.41	$151,564	13,854
2020-10-08	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	20,000	$0.00	$0	17,037
2020-10-08	BURWIG SUSAN E	Exec. VP, Operations	Exercise / conversion M	Common Stock	20,000	$14.41	$288,200	59,179
2020-10-06	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	50,000	$0.00	$0	0
2020-10-06	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	50,000	$23.00	$1,150,000	666,643
2020-10-05	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,592	$0.00	$0	65,305
2020-10-05	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,851	$0.00	$0	92,118
2020-10-05	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	2,592	$16.20	$41,990	6,785,855
2020-10-05	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	1,851	$14.41	$26,673	6,783,263
2020-08-31	Troendle August J.	President & CEO	Other disposed transaction J	Common Stock	9,354	$0.00	$0	6,781,412
2020-08-27	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	2,034	$121.94	$248,026	6,790,766
2020-08-26	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	13,889	$123.53	$1,715,708	6,792,800
2020-08-25	Troendle August J.	President & CEO	Open-market sell S	Common Stock	11,597	$123.23	$1,429,098	6,806,689
2020-08-24	Troendle August J.	President & CEO	Open-market sell S	Common Stock	18,903	$123.36	$2,331,874	6,818,286
2020-08-21	Troendle August J.	President & CEO	Open-market sell S	Common Stock	24,304	$124.37	$3,022,688	6,837,189
2020-08-20	Troendle August J.	President & CEO	Open-market sell S	Common Stock	18,813	$125.83	$2,367,240	6,861,493
2020-08-19	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	21,614	$127.63	$2,758,595	6,880,306
2020-08-18	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	16,589	$127.26	$2,111,116	6,901,920
2020-08-17	Troendle August J.	President & CEO	Open-market sell S	Common Stock	16,485	$128.18	$2,113,047	6,918,509
2020-08-17	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,500	$0.00	$0	15,010
2020-08-17	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	3,500	$128.00	$448,000	6,382
2020-08-17	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M	Common Stock	3,500	$23.00	$80,500	9,882
2020-08-14	Troendle August J.	President & CEO	Open-market sell S	Common Stock	16,857	$127.07	$2,142,019	6,934,994
2020-08-13	Troendle August J.	President & CEO	Open-market sell S	Common Stock	16,671	$127.87	$2,131,721	6,951,851
2020-08-12	Troendle August J.	President & CEO	Open-market sell S	Common Stock	21,916	$127.21	$2,787,934	6,968,522
2020-08-11	Troendle August J.	President & CEO	Open-market sell S	Common Stock	38,642	$125.30	$4,841,843	6,990,438
2020-08-10	Troendle August J.	President & CEO	Open-market sell S	Common Stock	48,148	$120.79	$5,815,797	7,029,080
2020-08-06	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	7,000	$126.00	$882,000	39,179
2020-08-05	Troendle August J.	President & CEO	Open-market sell S	Common Stock	13,179	$125.04	$1,647,902	7,112,203
2020-08-04	Troendle August J.	President & CEO	Open-market sell S	Common Stock	45,488	$124.43	$5,660,072	7,125,382
2020-08-03	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	27,005	$124.13	$3,352,131	7,170,870
2020-07-31	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	39,622	$118.17	$4,682,132	7,197,875
2020-07-30	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	42,955	$120.79	$5,188,534	7,237,497
2020-07-30	BURWIG SUSAN E	Exec. VP, Operations	Open-market sell S	Common Stock	6,000	$121.14	$726,840	46,179
2020-07-29	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	47,106	$123.99	$5,840,673	7,280,452
2020-07-28	Troendle August J.	President & CEO	Open-market sell S	Common Stock	214,499	$127.23	$27,290,708	7,327,558
2020-07-27	Troendle August J.	President & CEO	Open-market sell S	Common Stock	29,019	$110.43	$3,204,568	7,542,057
2020-07-24	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	34,380	$106.13	$3,648,749	7,571,076
2020-07-23	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	31,743	$111.83	$3,549,820	7,605,456
2020-07-22	Troendle August J.	President & CEO	Open-market sell S	Common Stock	35,878	$109.99	$3,946,221	7,637,199
2020-07-21	Troendle August J.	President & CEO	Open-market sell S	Common Stock	28,090	$106.78	$2,999,450	7,673,077
2020-07-20	Troendle August J.	President & CEO	Open-market sell S	Common Stock	17,735	$105.47	$1,870,510	7,701,167
2020-07-17	Troendle August J.	President & CEO	Open-market sell S	Common Stock	19,309	$105.32	$2,033,624	7,718,902
2020-07-16	Troendle August J.	President & CEO	Open-market sell S	Common Stock	15,273	$103.70	$1,583,810	7,738,211
2020-07-15	Troendle August J.	President & CEO	Open-market sell S	Common Stock	28,700	$104.90	$3,010,630	7,753,484
2020-07-13	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	6,127	$100.50	$615,764	7,782,184
2020-07-09	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	2,455	$100.15	$245,868	7,788,311
2020-05-15	King Tom C	Dir	Equity grant / award A · derivative	STOCK OPTION (RIGHT TO BUY)	3,858	$0.00	$0	3,858
2020-05-06	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,518	$0.00	$0	93,969
2020-05-06	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	3,518	$14.41	$50,694	7,790,766
2020-02-28	Troendle August J.	President & CEO	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	84,770	$0.00	$0	84,770
2020-02-28	Troendle August J.	President & CEO	Equity grant / award A	Common Stock	12,941	$0.00	$0	616,643
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,962	$0.00	$0	67,897
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	8,888	$0.00	$0	5,925
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	14,814	$0.00	$0	97,487
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M	Common Stock	2,962	$16.20	$47,984	7,787,248
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M	Common Stock	8,888	$14.41	$128,076	7,784,286
2020-01-31	Medpace Investors, LLC	10%	Exercise / conversion M	Common Stock	14,814	$14.41	$213,470	7,775,398
2019-12-20	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	16,948	$84.00	$1,423,632	0
2019-12-19	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	14,400	$82.00	$1,180,800	16,948
2019-11-15	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	555	$0.00	$0	70,859
2019-11-15	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	518	$0.00	$0	112,301
2019-11-15	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	555	$16.20	$8,991	7,760,584
2019-11-15	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	518	$14.41	$7,464	7,760,029
2019-10-24	King Tom C	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	3,021	$0.00	$0	3,021
2019-10-18	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	8,000	$77.30	$618,400	0
2019-10-15	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	9,600	$80.00	$768,000	31,348
2019-10-14	GEIGER JESSE J	CFO & COO, Lab Operations	Open-market sell S	Common Stock	7,200	$78.03	$561,816	40,948
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,851	$0.00	$0	71,414
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,222	$0.00	$0	14,813
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,313	$0.00	$0	112,819
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	1,851	$16.20	$29,986	7,759,511
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	2,222	$14.41	$32,019	7,757,660
2019-09-24	Troendle August J.	President & CEO	Exercise / conversion M	Common Stock	4,313	$14.41	$62,150	7,755,438
2019-09-24	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,851	$0.00	$0	71,414
2019-09-24	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,222	$0.00	$0	14,813
2019-09-24	Medpace Investors, LLC	10%	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,313	$0.00	$0	112,819
2019-09-13	Troendle August J.	President & CEO	Open-market buy P · derivative	Employee Stock Option (Right to Buy)	11,112	$36.77	$408,588	11,112
2019-09-13	Troendle August J.	President & CEO	Open-market buy P · derivative	Employee Stock Option (Right to Buy)	10,887	$38.12	$415,012	10,887
2019-09-13	Troendle August J.	President & CEO	Open-market buy P · derivative	Employee Stock Option (Right to Buy)	73,265	$38.80	$2,842,682	73,265
2019-09-13	Troendle August J.	President & CEO	Open-market buy P · derivative	Employee Stock Option (Right to Buy)	17,035	$40.59	$691,451	17,035
2019-09-13	Troendle August J.	President & CEO	Open-market buy P · derivative	Employee Stock Option (Right to Buy)	117,132	$40.59	$4,754,388	117,132
2019-08-05	GEIGER JESSE J	CFO & COO, Lab Operations	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	40,000	$0.00	$0	40,000
2019-05-17	Kraft Robert O.	Dir	Equity grant / award A · derivative	STOCK OPTION (RIGHT TO BUY)	6,472	$0.00	$0	6,472
2019-05-06	Brown Bruce	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	13,782	$0.00	$0	0
2019-05-06	Brown Bruce	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,500	$0.00	$0	0
2019-05-06	Brown Bruce	Dir	Other disposed transaction F	Common Stock	8,987	$58.31	$524,032	9,295
2019-05-06	Brown Bruce	Dir	Exercise / conversion M	Common Stock	13,782	$26.44	$364,396	18,282
2019-05-06	Brown Bruce	Dir	Exercise / conversion M	Common Stock	4,500	$29.09	$130,905	4,500
2019-05-02	Troendle August J.	President & CEO	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	234,259	$0.00	$0	234,259
2019-04-22	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	8,000	$0.00	$0	10,518
2019-04-22	EWALD STEPHEN P	General Counsel & Corp. Secy.	Exercise / conversion M	Common Stock	8,000	$14.41	$115,280	8,000
2019-04-05	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	48,148	$0.00	$0	0
2019-04-05	GEIGER JESSE J	CFO & COO, Lab Operations	Exercise / conversion M	Common Stock	48,148	$14.41	$693,813	48,148
2019-03-29	EWALD STEPHEN P	General Counsel & Corp. Secy.	Open-market sell S	Common Stock	7,946	$57.95	$460,471	0
2019-03-01	Troendle August J.	President & CEO	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	77,417	$0.00	$0	77,417
2019-02-04	Troendle August J.	President & CEO	Open-market sell S	Common Stock	18,920	$66.54	$1,258,937	7,751,125
2019-02-01	Troendle August J.	President & CEO	Open-market sell S	Common Stock	84,093	$65.54	$5,511,455	7,770,045
2019-01-31	Troendle August J.	President & CEO	Open-market sell S	Common Stock	68,383	$64.19	$4,389,505	7,854,138
2019-01-30	Troendle August J.	President & CEO	Open-market sell S	Common Stock	102,828	$63.22	$6,500,786	7,922,521
2019-01-29	Troendle August J.	President & CEO	Open-market sell S	Common Stock	1,100	$61.05	$67,155	8,025,349
2019-01-28	Troendle August J.	President & CEO	Open-market sell S	Common Stock	4,221	$61.04	$257,650	8,026,449
2019-01-25	Troendle August J.	President & CEO	Open-market sell S	Common Stock	27,958	$61.13	$1,709,073	8,030,670
2019-01-24	Troendle August J.	President & CEO	Open-market sell S	Common Stock	3,501	$61.14	$214,051	8,058,628
2019-01-23	Troendle August J.	President & CEO	Open-market sell S	Common Stock	24,160	$61.22	$1,479,075	8,062,129
2019-01-22	Troendle August J.	President & CEO	Open-market sell S	Common Stock	9,936	$61.10	$607,090	8,086,289
2019-01-18	Troendle August J.	President & CEO	Open-market sell S	Common Stock	38,318	$61.43	$2,353,875	8,096,225
2019-01-17	Troendle August J.	President & CEO	Open-market sell S	Common Stock	8,760	$61.17	$535,849	8,134,543
2019-01-17	Troendle August J.	President & CEO	Open-market sell S	Common Stock	8,760	$61.17	$535,849	8,134,543
2019-01-16	Troendle August J.	President & CEO	Open-market sell S	Common Stock	7,222	$61.57	$444,659	8,143,303
2019-01-16	Troendle August J.	President & CEO	Open-market sell S	Common Stock	7,222	$61.57	$444,659	8,143,303
2019-01-15	Troendle August J.	President & CEO	Open-market sell S	Common Stock	600	$61.00	$36,600	8,150,525
2019-01-15	Troendle August J.	President & CEO	Open-market sell S	Common Stock	600	$61.00	$36,600	8,150,525
2018-09-28	EWALD STEPHEN P	General Counsel & Corp. Secy.	Other acquired transaction J	Common Stock	7,946	$59.91	$476,045	7,946
2018-09-28	Troendle August J.	President & CEO	Other disposed transaction J	Common Stock	744,385	$59.91	$44,596,105	8,151,125
2018-09-27	Troendle August J.	President & CEO	Open-market sell S	Common Stock	46,778	$58.96	$2,758,031	8,895,510
2018-09-26	Troendle August J.	President & CEO	Open-market sell S	Common Stock	46,886	$58.38	$2,737,205	8,942,288
2018-09-25	Troendle August J.	President & CEO	Open-market sell S	Common Stock	38,640	$58.36	$2,255,030	8,989,174
2018-09-21	Troendle August J.	President & CEO	Open-market sell S	Common Stock	2,713	$58.47	$158,629	9,027,814
2018-09-20	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	53,842	$58.29	$3,138,450	9,030,527
2018-09-19	Medpace Investors, LLC	10%	Open-market sell S	Common Stock	61,141	$60.20	$3,680,810	9,084,369
2018-08-27	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	5,224,997	$54.75	$286,068,586	0
2018-08-13	McCarthy Cornelius P. III	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	4,710	$0.00	$0	4,710
2018-08-10	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	5,175,000	$54.35	$281,261,250	5,224,997
2018-08-06	Troendle August J.	President & CEO	Open-market sell S	Common Stock	156,369	$58.51	$9,149,150	489,956
2018-08-03	Troendle August J.	President & CEO	Open-market sell S	Common Stock	203,296	$59.94	$12,185,562	646,325
2018-08-02	Troendle August J.	President & CEO	Open-market sell S	Common Stock	371,795	$59.20	$22,010,264	849,621
2018-06-14	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	3,000,000	$41.80	$125,400,000	10,399,997
2018-05-18	Kraft Robert O.	Dir	Equity grant / award A · derivative	STOCK OPTION (RIGHT TO BUY)	8,127	$0.00	$0	8,127
2018-05-07	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	3,000,000	$35.49	$106,470,000	13,399,997
2018-02-28	GEIGER JESSE J	CFO & COO, Lab Operations	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	15,000	$0.00	$0	15,000
2017-12-05	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	4,600,000	$30.16	$138,741,980	16,399,997
2017-08-22	Medpace Limited Partnership	10%	Open-market sell S	Common Stock	2,000,000	$30.27	$60,540,000	20,999,997
2017-07-31	Medpace Investors, LLC	10%	Other disposed transaction J	Common Stock	37,037	$0.00	$0	9,145,510
2017-06-30	Medpace Investors, LLC	10%	Other disposed transaction J	Common Stock	27,571	$0.00	$0	9,182,547
2017-06-30	GEIGER JESSE J	CFO & COO, Lab Operations	Equity grant / award A	Common Stock	7,407	$0.00	$0	7,407
2017-06-21	Fifth Cinven Fund (No. 1) Limited Partnership	10%	Other disposed transaction J	Common Stock	22,999,997	$0.00	$0	0
2017-05-19	Kraft Robert O.	Dir	Equity grant / award A · derivative	STOCK OPTION (RIGHT TO BUY)	13,782	$0.00	$0	13,782
2017-05-02	BUCKNELL PENELOPE J	VP, Human Resources	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,000	$0.00	$0	11,814
2017-05-02	BUCKNELL PENELOPE J	VP, Human Resources	Exercise / conversion M	Common Stock	3,000	$14.41	$43,230	3,000
2017-03-15	GEIGER JESSE J	CFO & COO, Lab Operations	Equity grant / award A · derivative	EMPLOYEE STOCK OPTION (RIGHT TO BUY)	20,000	$0.00	$0	20,000
2016-11-01	Brown Bruce	Dir	Equity grant / award A · derivative	Stock Option (Right to Buy)	4,500	$0.00	$0	4,500
2016-08-18	Troendle August J.	President & CEO	Open-market buy P	COMMON STOCK	10,000	$27.98	$279,800	10,000
2016-08-17	BURWIG SUSAN E	Sr. Vice President, Operations	Open-market buy P	COMMON STOCK	18,000	$29.20	$525,600	19,211
2016-08-16	BURWIG SUSAN E	Sr. Vice President, Operations	Open-market buy P	COMMON STOCK	1,211	$29.30	$35,482	1,211
2016-08-10	Troendle August J.	President & CEO	Equity grant / award A · derivative	EMPLOYEE STOCK OPTION (RIGHT TO BUY)	50,000	$0.00	$0	50,000

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count